Subtopic Deep Dive
TGF-β Signaling in Pulmonary Fibrosis
Research Guide
What is TGF-β Signaling in Pulmonary Fibrosis?
TGF-β signaling in pulmonary fibrosis refers to the profibrotic cytokine pathways driving epithelial-mesenchymal transition (EMT), fibroblast activation, and extracellular matrix deposition in idiopathic pulmonary fibrosis (IPF).
TGF-β induces EMT in lung epithelial cells, generating myofibroblasts that promote fibrosis (Willis and Borok, 2007, 1025 citations). Overproduction of TGF-β leads to aberrant wound healing and collagen deposition in IPF lungs (Fernandez and Eickelberg, 2012, 661 citations). Single-cell RNA sequencing reveals diverse epithelial roles in these pathways (Xu et al., 2016, 583 citations).
Why It Matters
TGF-β signaling modulation targets core IPF mechanisms, as EMT contributes to fibroblast accumulation in fibrotic lesions (Willis and Borok, 2007). Selective inhibitors could halt progression, addressing unmet needs in bleomycin and IL-1β models where IL-17A amplifies TGF-β effects (Wilson et al., 2010, 722 citations). Clinical translation impacts therapies for airway remodeling and senescence-driven reepithelialization failures (Minagawa et al., 2010; Tatler and Jenkins, 2012).
Key Research Challenges
Selective TGF-β Inhibition
TGF-β drives fibrosis but also essential homeostasis, risking off-target effects with broad inhibitors (Fernandez and Eickelberg, 2012). Downstream mediators like TRPV4 must be targeted precisely for myofibroblast differentiation (Rahaman et al., 2014, 292 citations). Over 600 citations highlight need for isoform-specific approaches.
EMT Validation in Vivo
Debate persists on EMT's contribution to IPF fibroblasts despite in vitro evidence (Willis and Borok, 2007, 1025 citations). Single-cell data shows epithelial heterogeneity complicating lineage tracing (Xu et al., 2016, 583 citations). Fate-mapping studies are needed.
Senescence-Fibrosis Crosstalk
TGF-β accelerates epithelial senescence via SIRT6 inhibition, impairing repair (Minagawa et al., 2010, 320 citations). Integrating senescence markers with TGF-β pathways remains unresolved. Bleomycin models link this to IL-17A dependence (Wilson et al., 2010).
Essential Papers
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
Brigham C. Willis, Zea Borok · 2007 · American Journal of Physiology-Lung Cellular and Molecular Physiology · 1.0K citations
Epithelial-mesenchymal transition (EMT), a process whereby fully differentiated epithelial cells undergo transition to a mesenchymal phenotype giving rise to fibroblasts and myofibroblasts, is incr...
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Mark S. Wilson, Satish K. Madala, Thirumalai R. Ramalingam et al. · 2010 · The Journal of Experimental Medicine · 722 citations
Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. To better understand the inflammatory responses that precede and concur with collagen dep...
The Impact of TGF-β on Lung Fibrosis
Isis E. Fernandez, Oliver Eickelberg · 2012 · Proceedings of the American Thoracic Society · 661 citations
Transforming growth factor-β (TGF-β) is extensively involved in the development of fibrosis in different organs. Overproduction or potentiation of its profibrotic effects leads to an aberrant wound...
Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis
Yan Xu, Takako Mizuno, Anusha Sridharan et al. · 2016 · JCI Insight · 583 citations
Idiopathic pulmonary fibrosis (IPF) is a lethal interstitial lung disease characterized by airway remodeling, inflammation, alveolar destruction, and fibrosis. We utilized single-cell RNA sequencin...
Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells
Shunsuke Minagawa, Jun Araya, Takanori Numata et al. · 2010 · American Journal of Physiology-Lung Cellular and Molecular Physiology · 320 citations
Reepithelialization of remodeled air spaces with bronchial epithelial cells is a prominent pathological finding in idiopathic pulmonary fibrosis (IPF) and is implicated in IPF pathogenesis. Recent ...
TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice
Shaik O. Rahaman, L. Grove, Sailaja Paruchuri et al. · 2014 · Journal of Clinical Investigation · 292 citations
Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disorder with no effective medical treatments available. The generation of myofibroblasts, which are critical for fibrogenesis, requires...
The pathogenesis of idiopathic pulmonary fibrosis
William R. Coward, Gauri Saini, Gísli Jenkins · 2010 · Therapeutic Advances in Respiratory Disease · 274 citations
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an appalling prognosis. The failure of anti-inflammatory therapies coupled with the observation that deranged epithel...
Reading Guide
Foundational Papers
Start with Willis and Borok (2007, 1025 citations) for EMT mechanisms; Fernandez and Eickelberg (2012, 661 citations) for TGF-β overview; Wilson et al. (2010, 722 citations) for IL-17A models linking inflammation to fibrosis.
Recent Advances
Study Xu et al. (2016, 583 citations) for scRNA-seq epithelial diversity; Rahaman et al. (2014, 292 citations) for TRPV4-TGF-β in myofibroblasts; Yao et al. (2016, 255 citations) for Chop in M2 macrophages.
Core Methods
Core techniques: bleomycin-induced fibrosis models (Wilson 2010), single-cell RNA-seq (Xu 2016), SIRT6 modulation in bronchial epithelia (Minagawa 2010), TRPV4 knockout mice (Rahaman 2014).
How PapersFlow Helps You Research TGF-β Signaling in Pulmonary Fibrosis
Discover & Search
Research Agent uses searchPapers and citationGraph to map 1000+ citations from Willis and Borok (2007), revealing EMT clusters connected to Fernandez and Eickelberg (2012). exaSearch uncovers downstream inhibitors; findSimilarPapers expands from Xu et al. (2016) scRNA-seq to epithelial subtypes.
Analyze & Verify
Analysis Agent applies readPaperContent to extract TGF-β pathway schematics from Tatler and Jenkins (2012), then verifyResponse with CoVe checks claims against 10 related papers. runPythonAnalysis performs GRADE grading on senescence data from Minagawa et al. (2010), computing statistical significance of SIRT6 effects via pandas.
Synthesize & Write
Synthesis Agent detects gaps in TRPV4-TGF-β integration (Rahaman et al., 2014) and flags EMT contradictions across Willis (2007) and Xu (2016). Writing Agent uses latexEditText for pathway revisions, latexSyncCitations for 20-paper bibliographies, and exportMermaid for EMT diagrams; latexCompile generates IPF review manuscripts.
Use Cases
"Analyze TGF-β senescence data from Minagawa 2010 with statistics."
Research Agent → searchPapers('Minagawa SIRT6 TGF-β') → Analysis Agent → readPaperContent → runPythonAnalysis (pandas t-test on senescence rates, matplotlib plots) → GRADE B evidence report with p-values.
"Write LaTeX review on TGF-β EMT in IPF citing Willis 2007."
Synthesis Agent → gap detection (EMT validation gaps) → Writing Agent → latexEditText (intro section) → latexSyncCitations (add 15 papers) → latexCompile → PDF with TGF-β pathway figure.
"Find code for scRNA-seq analysis of IPF epithelial cells like Xu 2016."
Research Agent → paperExtractUrls('Xu 2016 JCI Insight') → paperFindGithubRepo → githubRepoInspect (Seurat scripts for TGF-β clusters) → runPythonAnalysis (re-run on new data).
Automated Workflows
Deep Research workflow scans 50+ TGF-β papers via citationGraph from Willis (2007), generating structured reports with EMT timelines. DeepScan applies 7-step CoVe to verify TRPV4 claims (Rahaman 2014) against scRNA-seq (Xu 2016). Theorizer builds hypotheses on SIRT6-TGF-β networks from Minagawa (2010).
Frequently Asked Questions
What defines TGF-β signaling in pulmonary fibrosis?
TGF-β signaling drives EMT, myofibroblast differentiation, and matrix deposition in IPF via Smad and non-Smad pathways (Willis and Borok, 2007; Fernandez and Eickelberg, 2012).
What are key methods studying TGF-β in IPF?
Methods include bleomycin/IL-17A mouse models (Wilson et al., 2010), scRNA-seq for epithelial states (Xu et al., 2016), and SIRT6 knockdown for senescence (Minagawa et al., 2010).
What are seminal papers on this topic?
Willis and Borok (2007, 1025 citations) on EMT; Fernandez and Eickelberg (2012, 661 citations) on TGF-β impact; Rahaman et al. (2014, 292 citations) on TRPV4 mediation.
What open problems exist?
Challenges include proving in vivo EMT, developing selective inhibitors sparing homeostasis, and resolving senescence-TGF-β links (Willis 2007; Minagawa 2010; Rahaman 2014).
Research Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching TGF-β Signaling in Pulmonary Fibrosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers